This provided a very strong incentive to investigate the role of human cDC1 in antitumor immunity, considering the body of evidence discussed above supporting a critical role of mouse cDC1 in promoting NK- and CTL-mediated tumor control in preclinical cancer models. This evidence concerns the gene MPPE1 and neoplasm.